Periodic Reporting for period 1 - EUthyroid2 (The next step towards the elimination of iodine deficiency and preventable iodine-related disorders in Europe)
Berichtszeitraum: 2023-01-01 bis 2024-06-30
Iodine deficiency is the world’s leading cause of thyroid disorders and the single most important and preventable cause of brain damage. For women getting pregnant, even mild-to-moderate ID during pregnancy is related to neurocognitive impairment in the offspring. Therefore, EUthyroid as an EU-funded public health consortium targets the elimination of iodine deficiency and related preventable disorders in Europe.
After uncovering low awareness on the importance of iodine for healthy living within the frame of EUthyroid, the main objective of EUthyroid2 is to fill important gaps in the prevention of iodine deficiency in Europe and beyond.
An important step is the improvement of that low awareness with respect to iodine-related risks in adolescents and young woman. For this purpose, implementation studies and community-based randomized-controlled trials will be conducted with interventions performed in the educational system and ambulatory care in eight study regions.
By finding the best practice models, EUthyroid2 will lay the foundation for a cost-effective way to eradicate iodine deficiency-related disorders.
After uncovering low awareness on the importance of iodine for healthy living within the frame of EUthyroid, the main objective of EUthyroid2 is to fill important gaps in the prevention of iodine deficiency in Europe and beyond.
An important step is the improvement of that low awareness with respect to iodine-related risks in adolescents and young woman. For this purpose, implementation studies and community-based randomized-controlled trials will be conducted with interventions performed in the educational system and ambulatory care in eight study regions.
By finding the best practice models, EUthyroid2 will lay the foundation for a cost-effective way to eradicate iodine deficiency-related disorders.
There will be two intervention studies in the EUthyroid2 project with the objective of increasing IDD-related awareness in adolescents and young women up to age of 24 before pregnancy.
The instruments were developed for both interventions (ambulatory care setting and educational setting) and adapted or edited to take account of cultural differences in the respective study regions. Questionnaires were developed to measure success. The intervention instruments and the data collection instruments were translated into the respective national languages and tested. This process has not yet been completed for all study regions, but is in the final stages so that the roll-out can begin shortly. The infrastructure for centralised data collection has been created.
A manuscript on the study design has been drafted and is currently being reviewed by the co-authors.
The instruments were developed for both interventions (ambulatory care setting and educational setting) and adapted or edited to take account of cultural differences in the respective study regions. Questionnaires were developed to measure success. The intervention instruments and the data collection instruments were translated into the respective national languages and tested. This process has not yet been completed for all study regions, but is in the final stages so that the roll-out can begin shortly. The infrastructure for centralised data collection has been created.
A manuscript on the study design has been drafted and is currently being reviewed by the co-authors.
So far, all intervention tools have been developed but not yet used, so that no results regarding their effectiveness are available at this time